Genomic array as compared to karyotyping in myelodysplastic syndromes in a prospective clinical trial.

about

Genomic array as compared to karyotyping in myelodysplastic syndromes in a prospective clinical trial.

Item

http://www.wikidata.org/entity/Q36290615

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Genomic array as compared to k ...... a prospective clinical trial.

@ast

Genomic array as compared to k ...... a prospective clinical trial.

@en

type

Item

label

Genomic array as compared to k ...... a prospective clinical trial.

@ast

Genomic array as compared to k ...... a prospective clinical trial.

@en

prefLabel

Genomic array as compared to k ...... a prospective clinical trial.

@ast

Genomic array as compared to k ...... a prospective clinical trial.

@en

P1476

Genomic array as compared to k ...... a prospective clinical trial.

@en

P2093

Arjan A van de Loosdrecht

http://www.w3.org/2001/XMLSchema#string

Bert van der Reijden

http://www.w3.org/2001/XMLSchema#string

Canan Alhan

http://www.w3.org/2001/XMLSchema#string

Dana A Chitu

http://www.w3.org/2001/XMLSchema#string

Daniel Olde Weghuis

http://www.w3.org/2001/XMLSchema#string

Edo Vellenga

http://www.w3.org/2001/XMLSchema#string

Eline M P Cremers

http://www.w3.org/2001/XMLSchema#string

Georgine E de Greef

http://www.w3.org/2001/XMLSchema#string

Gert J Ossenkoppele

http://www.w3.org/2001/XMLSchema#string

Heleen A Visser-Wisselaar

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

FISH and SNP-A karyotyping in myelodysplastic syndromes: improving cytogenetic detection of del(5q), monosomy 7, del(7q), trisomy 8 and del(20q)

Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML

Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes.

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

The World Health Organization (WHO) classification of the myeloid neoplasms

Efficacy of lenalidomide in myelodysplastic syndromes.

Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies

Accurate detection of uniparental disomy and microdeletions by SNP array analysis in myelodysplastic syndromes with normal cytogenetics.

Revised international prognostic scoring system for myelodysplastic syndromes.

P304

524-534

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/GCC.22455

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Petra Muus

P577

2017-02-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28236351

http://www.w3.org/2001/XMLSchema#string

P921

karyotype